n-3 fatty acids and cardiac autonomic function in humans

Cellular and Molecular Biology

Volumn 56, Issue 1, 2010, Pages 131-139

  Christensen, J H ^a   Svensson, M ^a   Strandhave, C ^a   Madsen, T ^a   Schmidt, E B ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autonomic function; Heart rate variability; Marine n 3 polyunsaturated fatty acids; Sudden cardiac death

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SUNFLOWER OIL;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BRAIN; CARDIOVASCULAR RISK; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIABETES MELLITUS; DIALYSIS; DIET SUPPLEMENTATION; ELECTROCARDIOGRAM; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE VARIABILITY; HEART VENTRICLE ARRHYTHMIA; HEMODIALYSIS; HIGH RISK PATIENT; HUMAN; INSULIN TREATMENT; ISCHEMIC HEART DISEASE; NERVOUS TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; TREATMENT DURATION; AUTONOMIC NERVOUS SYSTEM; DRUG EFFECT; HEART; HEART MUSCLE ISCHEMIA; HEART RATE; INNERVATION; MORTALITY; PATHOPHYSIOLOGY; SUDDEN DEATH;

AUTONOMIC NERVOUS SYSTEM; DEATH, SUDDEN, CARDIAC; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HEART; HEART RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MYOCARDIAL ISCHEMIA;

EID: 77953633163     PISSN: 01455680     EISSN: 1165158X     Source Type: Journal    
DOI: 10.1170/T885     Document Type: Article

References (77)

1. Airaksinen, K.E., Autonomic mechanisms and sudden death after abrupt coronary occlusion. Ann Med. 1999, 31: 240-245.
2. Albert, C.M., Campos, H., Stampfer, M.J., Ridker, P.M., Manson, J.E., Willett, W.C. and Ma, J., Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med. 2002, 346: 1113-1118.
3. Albert, C.M., Hennekens, C.H., O'Donnell, C.J., Ajani, U.A., Carey, V.J., Willett, W.C., Ruskin, J.N. and Manson, J.E., Fish consumption and risk of sudden cardiac death. JAMA. 1998, 279: 23-28.
4. Barron, H.V. and Lesh, M.D., Autonomic nervous system and sudden cardiac death. J Am Coll Cardiol. 1996, 27: 1053-1060.
5. Bigger, J.T. Jr., Fleiss, J.L., Steinman, R.C., Rolnitzky, L.M., Kleiger, R.E. and Rottman, J.N., Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992, 69: 891-898.
6. Billman, G.E., Schwartz, P.J. and Stone, H.L., Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation. 1982, 66: 874-880.
7. Binkley, P.F., Haas, G.J., Starling, R.C., Nunziata, E., Hatton, P.A., Leier, C.V. and Cody, R.J., Sustained augmentation of parasympathetic tone with angiotensin-converting enzyme inhibition in patients with congestive heart failure. J Am Coll Cardiol. 1993, 21: 655-661.
8. Brouwer, I.A., Zock, P.L., van Amelsvoort, L.G., Katan, M.B. and Schouten, E.G., Association between n-3 fatty acid status in blood and electrocardiographic predictors of arrhythmia risk in healthy volunteers. Am J Cardiol. 2002, 89: 629-631.
9. Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetnam, P.M., Elwood, P.C. and Deadman, N.M., Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet. 1989, 2: 757-761.
10. Burr, M.L., Fehily, A.M., Rogers, S., Welsby, E., King, S. and Sandham, S., Diet and reinfarction trial (DART): design, recruitment, and compliance. Eur Heart J. 1989, 10: 558-567.
11. Christensen, J.H., Aaroe, J., Knudsen, N., Dideriksen, K., Kornerup, H.J., Dyerberg, J. and Schmidt, E.B., Heart rate variability and n-3 fatty acids in patients with chronic renal failure-a pilot study. Clin Nephrol. 1998, 49: 102-106.
12. Christensen, J.H., Christensen, M.S., Dyerberg, J. and Schmidt, E.B., Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. Am J Clin Nutr. 1999, 70: 331-337.
13. Christensen, J.H., Gustenhoff, P., Korup, E, Aarøe, J., Toft, E., Møller, J., Rasmussen, K., Dyerberg, J. and Schmidt, E.B., Effect of fish oil on heart rate variability in survivors of myocardial infarction: a double blind randomised controlled trial. BMJ. 1996, 312: 677-678.
14. Christensen, J.H., Korup, E., Aaroe, J., Toft, E., Møller, J., Rasmussen, K., Dyerberg, J. and Schmidt, E.B., Fish consumption, n-3 fatty acids in cell membranes, and heart rate variability in survivors of myocardial infarction with left ventricular dysfunction. Am J Cardiol. 1997, 79: 1670-1673.
15. Christensen, J.H., Skou, H.A., Fog, L., Hansen, V., Vesterlund, T., Dyerberg, J., Toft, E. and Schmidt, E.B., Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography. Circulation. 2001, 103: 651-657.
16. Christensen, J.H., Skou, H.A., Madsen, T., Torring, I. and Schmidt, E.B., Heart rate variability and n-3 polyunsaturated fatty acids in patients with diabetes mellitus. J Intern Med. 2001, 249: 545-552.
17. Dekker, J.M., Schouten, E.G., Klootwijk, P., Pool, J., Swenne, C.A. and Kromhout, D., Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 1997, 145: 899-908.
18. Fauchier, L., Babuty, D., Autret, M.L., Poret, P., Cosnay, P. and Fauchier, J.P., Effect of flecainide on heart rate variability in subjects without coronary artery disease or congestive heart failure. Cardiovasc Drugs Ther. 1998, 12: 483-486.
19. Fiedler, R., Mall, M., Wand, C. and Osten, B., Short-term administration of omega-3 fatty acids in hemodialysis patients with balanced lipid metabolism. J Ren Nutr. 2005, 15: 253-256.
20. Friedman, A. and Moe, S.. Review of the effects of omega-3 supplementation in dialysis patients. Clin J Am Soc Nephrol. 2006, 1: 182-192.
21. Geelen, A., Zock, P.L., Swenne, C.A., Brouwer, I.A., Schouten, E.G. and Katan, M.B., Effect of n-3 fatty acids on heart rate variability and baroreflex sensitivity in middle-aged subjects. Am Heart J. 2003, 146: E4.
22. Goldsmith, R.L., Bigger, J.T., Bloomfield, D.M., Krum, H., Steinman, R.C., Sackner-Bernstein, J. and Packer, M., Long-term carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failure. Am J Cardiol. 1997, 80: 1101-1104.
23. Grimsgaard, S., Bonaa, K.H., Hansen, J.B. and Myhre, E.S., Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans. Am J Clin Nutr. 1998, 68:52-59.
24. Hamaad, A., Kaeng, L.W., Lip, G.Y. and MacFadyen, R.J., Oral omega n3-PUFA therapy (Omacor) has no impact on indices of heart rate variability in stable post myocardial infarction patients. Cardiovasc Drugs Ther. 2006, 20: 359-364.
25. Hayano, J., Takahashi, H., Toriyama, T., Mukai, S., Okada, A., Sakata, S., Yamada, A., Ohte, N. and Kawahara, H., Prognostic value of heart rate variability during long-term follow-up in chronic haemodialysis patients with end-stage renal disease. Nephrol Dial Transplant. 1999, 14: 1480-1488.
26. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation. 1996, 93: 1043-1065.
27. Herzog, C.A., Mangrum, J.M. and Passman, R., Sudden cardiac death and dialysis patients. Semin Dial. 2008, 21: 300-307.
28. Hohnloser, S.H., Klingenheben, T. Zabel, M. and Just, H., Effect of sotalol on heart rate variability assessed by Holter monitoring in patients with ventricular arrhythmias. Am J Cardiol. 1993, 72: 67A-71A.
29. Holguin, F., Tellez-Rojo, M.M., Lazo, M., Mannino, D., Schwartz, J., Hernández, M. and Romieu, I., Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly. Chest. 2005, 127: 1102-1107.
30. Kleiger, R.E., Bigger, J.T., Bosner, M.S. Chung, M.K., Cook, J.R., Rolnitzky, L.M., Steinman, R. and Fleiss, J.L., Stability over time of variables measuring heart rate variability in normal subjects. Am J Cardiol. 1991, 68: 626-630.
31. Kleiger, R.E., Stein, P.K. and Bigger, J.T. Jr., Heart rate variability: measurement and clinical utility. Ann Noninvasive Electrocardiol. 2005, 10: 88-101.
32. Kleiger, R.E., Stein, P.K., Bosner, M.S. and Rottman, J.N., Time domain measurements of heart rate variability. Cardiol Clin. 1992, 10: 487-498.
33. La Rovere, M.T., Bigger, J.T. Jr., Marcus, F.I., Mortara, A. and Schwartz, P.J., Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998, 351: 478-484.
34. Mak, K.H. and Topol, E.J., Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus. J Am Coll Cardiol. 2000, 35: 563-568.
35. Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., Franzosi, M.G., Geraci, E., Levantesi, G., Maggioni, A.P., Mantini, L., Marfisi, R.M., Mastrogiuseppe, G., Mininni, N., Nicolosi, G.L., Santini, M., Schweiger, C., Tavazzi, L., Tognoni, G., Tucci, C. and Valagussa, F., Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation. 2002, 105: 1897-1903.
36. Maser, R.E. and Lenhard, M.J., Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005, 90: 5896-5903.
37. Molgaard, H., Mickley, H., Pless, P., Bjerregaard, P. and Moller, M., Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction. Am J Cardiol. 1993, 71: 1357-1359.
38. Molgaard, H., Sorensen, K.E. and Bjerregaard, P., Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991, 1: 233-237.
39. Mozaffarian, D., Geelen, A., Brouwer, I.A., Geleijnse, J.M., Zock, P.L. and Katan, M.B., Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials. Circulation. 2005, 112: 1945-1952.
40. Mozaffarian, D., Stein, P.K., Prineas, R.J. and Siscovick, D.S., Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation. 2008, 117: 1130-1137.
41. Ninio, D.M., Hill, A.M., Howe, P.R., Buckley, J.D. and Saint, D.A., Docosahexaenoic acid-rich fish oil improves heart rate variability and heart rate responses to exercise in overweight adults. Br J Nutr. 2008, 100: 1097-1103.
42. Oikawa, K., Ishihara, R., Maeda, T., Yamaguchi, K., Koike, A., Kawaguchi, H., Tabata, Y., Murotani, N. and Itoh, H., Prognostic value of heart rate variability in patients with renal failure on hemodialysis. Int J Cardiol. 2009, 131: 370-377.
43. O'Keefe Jr., J.H., Abuissa, H., Sastre, A., Steinhaus, D.M. and Harris, W.S., Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions. Am J Cardiol. 2006, 97: 1127-1130.
44. Palatini, P. and Julius, S., Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens. 2004, 26: 637-644.
45. Pedretti, R.F., Colombo, E., Sarzi, B.S. and Caru, B., Effect of thrombolysis on heart rate variability and life-threatening ventricular arrhythmias in survivors of acute myocardial infarction. J Am Coll Cardiol. 1994, 23: 19-26.
46. Sandrone, G., Mortara, A., Torzillo, D., La Rovere, M.T., Malliani, A. and Lombardi, F., Effects of beta blockers (atenolol or metoprolol) on heart rate variability after acute myocardial infarction. Am J Cardiol. 1994, 74: 340-345.
47. Santini, V., Ciampittiello, G., Gigli, F., Bracaglia, D., Baroni, A., Cicconetti, E., Verri, C., Gambardella, S. and Frontoni, S., QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA. Nutr Metab Cardiovasc Dis. 2007, 17: 712-718.
48. Schwartz, P.J., Billman, G.E. and Stone, H.L., Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. Circulation. 1984, 69: 790-800.
49. Schwartz, P.J., La Rovere, M.T. and Vanoli, E., Autonomic nervous system and sudden cardiac death. Experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992, 85: I77-I91.
50. Schwartz, P.J., The autonomic nervous system and sudden death. Eur Heart J. 1998, 19 Suppl F: F72-F80.
51. Siscovick, D.S., Raghunathan, T., King, I., Weinmann, S., Bovbjerg, V.E., Kushi, L., Cobb, L.A., Copass, M.K., Psaty, B.M., Lemaitre, R., Retzlaff, B. and Knopp, R.H., Dietary intake of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. Am J Clin Nutr. 2000, 71: 208S-212S.
52. Siscovick, D.S., Raghunathan, T.E., King, I., Weinmann, S., Wicklund, K.G., Albright, J., Bovbjerg, V., Arbogast, P., Smith, H., Kushi, L.H., Cobb, L.A., Copass, M.K., Psaty, B. M., Lemaitre, R., Retzlaff, B., Childs M., and Knopp, R., Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995, 274: 1363-1367.
53. Stein, P.K. and Kleiger, R.E., Insights from the study of heart rate variability. Annu Rev Med. 1999, 50: 249-261.
54. Stein, P.K., Rottman, J.N., Kuru, T. and Kleiger, R.E., Effect of moricizine on heart rate variability in normal subjects. Int J Cardiol. 1995, 48: 59-65.
55. Svensson, M., Schmidt, E.B., Jorgensen, K.A. and Christensen, J.H., The effect of n-3 fatty acids on heart rate variability in patients treated with chronic hemodialysis. J Ren Nutr. 2007, 17: 243-249.
56. Tibblin, G., Eriksson, C.-G., Bjurö, T., Georgescu, D. and Svärdsudd, C., Heart rate and heart rate variability a risk factor for the development of ischaemic heart disease (IHD) in the "men born in 1913 study" - a ten years follow-up. Med Sci Cardiovasc Sys Soc Occup. 1975, 3: 95.
57. Tsuji, H., Larson, M.G., Venditti, F.J. Jr., Manders, E.S., Evans, J.C., Feldman, C.L. and Levy, D., Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996, 94: 2850-2855.
58. Tsuji, H., Venditti, F.J. Jr., Manders, E.S., Evans, J.C., Larson, M.G., Feldman, C.L. and Levy, D., Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994, 90: 878-883.
59. Villa, B., Calabresi, L., Chiesa, G., Rise, P., Galli, C. and Sirtori, C.R., Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. Pharmacol Res. 2002, 45: 475.
60. Youdim, K.A., Martin, A. and Joseph, J.A., Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. 2000, 18: 383-399.
61. Zabel, M., Klingenheben, T. and Hohnloser, S.H., Changes in autonomic tone following thrombolytic therapy for acute myocardial infarction: assessment by analysis of heart rate variability. J Cardiovasc Electrophysiol. 1994, 5: 211-218.
62. Zhang, Y.H., Song, Y.C., Zhu, J., Hu, T.H. and Wan, L.L., Effects of enalapril on heart rate variability in patients with congestive heart failure. Am J Cardiol. 1995, 76: 1045-1048.
63. Zipes, D.P. and Wellens, H.J., Sudden cardiac death. Circulation. 1998, 98: 2334-2351.
64. Zuanetti, G., Latini, R., Neilson, J.M., Schwartz, P.J. and Ewing, D.J., Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG). J Am Coll Cardiol. 1991, 17: 604-612.
65. Zuanetti, G., Neilson, J.M., Latini, R., Santoro, E., Maggioni, A.P. and Ewing, D.J., Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico. Circulation. 1996, 94: 432-436.
66. Andersen, V.L., Vogt, J., Obel, T., Christensen, J.H., Schmidt, E.B., The effect of n-3 fatty acids on plasma myeloperoxidase levels in healthy adults. Cell. Mol. Biol. 2010, 56(1): 3-9.
67. Andreasen, J. J., Aardestrup, I. V., Eschen, R. B., Obel, T., Lundbye-Christensen, S., Schmidt, E. B., Fatty acid composition of the internal mammary artery in relation to dietary intake of marine n-3 polyunsaturated fatty acids and association with flow-mediated vasodilation. Cell. Mol. Biol. 2010, 56(1): 10-17.
68. Arnesen, H., Seljeflot, I., Studies on very long chain marine n-3 fatty acids in patients with atherosclerotic heart disease with special focus on mechanisms, dosage and formulas of supplementation. Cell. Mol. Biol. 2010, 56(1): 18-27.
69. Calder, P.C., Yaqoob, P., Omega-3 (n-3) fatty acids, cardiovascular disease and stability of atherosclerotic plaques. Cell. Mol. Biol. 2010, 56(1): 28-37.
70. Petersen, M.M., Eschen, R.B., Aardestrup, I., Obel, T., Schmidt, E.B., Flow-mediated vasodilation and dietary intake of n-3 polyunsaturated acids in healthy subjects. Cell. Mol. Biol. 2010, 56(1): 38-44.
71. Eschen, O., Christensen, J.H., La rovere, M.T., Romano, P., Sala, P., Schmidt, E.B., Effects of marine n-3 fatty acids on circulating levels of soluble adhesion molecules in patients with chronic heart failure. Cell. Mol. Biol. 2010, 56(1): 45-51.
72. Isherwood, C., Wong, M., Jones, W.S., Davies, I.G., Griffin, B.A., lack of effect of cold water prawns on plasma cholesterol and lipoproteins in normo-lipidaemic men. Cell. Mol. Biol. 2010, 56(1): 52-58.
73. Massaro, M., Scoditti, E., Carluccio, M. A., Campana, M. C., De caterina, R., Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils. Cell. Mol. Biol. 2010, 56(1): 59-82.
74. Mori, T. A., Omega-3 fatty acids and blood pressure. Cell. Mol. Biol. 2010, 56(1): 83-92.
75. Von Schacky, C., Omega-3 fatty acids vs. cardiac disease - the contribution of the omega-3 index. Cell. Mol. Biol. 2010, 56(1): 93-101.
76. 2-macroglobulin in healthy subjects after supplementation with different doses of marine n-3 fatty acids. Cell. Mol. Biol. 2010, 56(1): 102-109.
77. Marchioli, R., Silletta, M.G., Levantesi, G., Pioggiarella, R., Tognoni, G., N-3 polyunsaturated fatty acids in heart failure: mechanisms and recent clinical evidence. Cell. Mol. Biol. 2010, 56(1): 110-130.